Target intelligence / Profile preview

Endoglucanase 5A (Cel5A)

Target
Cel5A
Molecular classification
Enzyme, Glycoside hydrolase, Glycoside hydrolase family 5 (GH5)
01

Overview

**Endoglucanase 5A** is a member of the glycoside hydrolase family 5 (GH5) and functions as an **endo-1,4-β-glucanase**. It catalyzes the random hydrolytic cleavage of internal (1→4)-β-D-glycosidic bonds in cellulose, a major structural carbohydrate in plant cell walls, as well as in other β-D-glucans such as lichenin and cereal β-D-glucans[7][9][4][1][5]. Structurally, this enzyme typically comprises a catalytic GH5 domain which may be associated with additional carbohydrate-binding modules (e.g., CBM1), contributing to substrate recognition and catalytic activity[2][4]. Endoglucanase 5A is produced by various microorganisms (including fungi and bacteria) where it plays a critical role in biomass decomposition and nutrient cycling[4][1][8]. Biotechnologically, Endoglucanase 5A is valued for its use in lignocellulose bioconversion (e.g., production of biofuels), animal feed, and various industrial applications. There is no direct implication of Endoglucanase 5A in human disease or traditional therapeutic targeting, and it is not currently considered a therapeutic drug target.

Other names
Endo-1,4-β-glucanase 5ACel5AEG 5AGlycoside hydrolase family 5 endoglucanase
02

Mechanism of action

Catalyzes endohydrolysis of (1→4)-β-D-glucosidic linkages in cellulose, lichenin, and cereal β-D-glucans, breaking down polysaccharides into shorter oligosaccharides and glucose[7][9][4][2][1].

03

Biological functions

Cellulose degradationHydrolysis of β-1,4-glycosidic bonds in cellulose and other β-D-glucansLignocellulosic biomass conversion
04

Disease associations

Other (mainly biotechnological/industrial relevance; no established human disease relevance)
05

Safety considerations

Potential for allergenicity in industrial/biotechnology exposure; otherwise not applicable to therapeutic use

Beyond the preview

Go deeper on Endoglucanase 5A (Cel5A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endoglucanase 5A (Cel5A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call